锘� Moderna says COVID-19 vaccine 94.5% effective | Inquirer 黑料社

.simplePullQuote{--wpr-bg-69f7f2c4-de7a-4a01-8a2e-ed34ea698411: url('/single2017/images/quote-2021.png');}.simplePullQuote{--wpr-bg-0bf7fef9-7b93-41b2-9cc3-70a9292b789e: url('/single2017/images/quote-texture.png');}.simplePullQuote{--wpr-bg-62722b20-9adf-4beb-92c9-3ebde01238bb: url('/single2017/images/quote-2021.png');}.simplePullQuote{--wpr-bg-ce90b70c-635d-42a4-8eeb-822c62a9bef4: url('/single2017/images/quote-texture.png');}.simplePullQuote{--wpr-bg-3ec75d2c-ead1-48e2-a5ee-b3f6a254eaf6: url('/single2017/images/quote-2021.png');}.simplePullQuote{--wpr-bg-623014d5-5cf1-448e-acf7-2e5090ad6d6d: url('/single2017/images/quote-texture.png');}.simplePullQuote{--wpr-bg-9ae5b53d-4989-4c31-87c2-35766f56d244: url('/single2017/images/quote-2021.png');}.simplePullQuote{--wpr-bg-d185f105-4c21-455d-b7d5-668652bbe57f: url('/single2017/images/quote-texture.png');}.simplePullQuote{--wpr-bg-868bce1e-14b4-4532-95f9-e86188db481a: url('/single2017/images/quote-2021.png');}.simplePullQuote{--wpr-bg-b984ba58-97b1-4534-8840-d70463f12ea2: url('/single2017/images/quote-texture.png');}.simplePullQuote{--wpr-bg-c0b2c6ce-fadb-4560-b1c7-2544cafad5ab: url('/single2017/images/quote-2021.png');}.simplePullQuote{--wpr-bg-4b9a0864-0c06-47d0-a9b1-5f9a4ee8b2f6: url('/single2017/images/quote-texture.png');}.simplePullQuote{--wpr-bg-ac1dbcc4-bf12-4165-b410-d5825cddaafc: url('/single2017/images/quote-2021.png');}.simplePullQuote{--wpr-bg-2f618e67-7de0-4a2e-9e91-ebaf54ff680f: url('/single2017/images/quote-texture.png');}.sib-flag{--wpr-bg-f099a9ec-addf-4f76-953b-6c096c3e016e: url('https://static.brevo.com/images/flags.png');}.simplePullQuote{--wpr-bg-61b522c5-2cf9-4101-8e09-6e54c7cb9c35: url('/wp-content/plugins/simple-pull-quote/images/quote.png');}.rll-youtube-player .play{--wpr-bg-0274e8ba-4cab-4a7f-879e-0cb4d3ecd09d: url('/wp-content/plugins/wp-rocket/assets/img/youtube.png');}#inq-banner-2021-FT-survey{--wpr-bg-cc118b4d-f45a-4832-b09e-5cc16f1cf28f: url('https://www.inquirer.net/wp-content/uploads/2024/12/SMDC-HenrySy_980x80.gif');}#inq-banner-2021-FT-survey{--wpr-bg-7cb4b04f-d5fc-4bb3-9472-c00a2883a0e0: url('https://www.inquirer.net/wp-content/uploads/2024/12/SMDC-HenrySy_980x80.gif');}#inq-banner-2021-FT-survey{--wpr-bg-87432ee5-64ce-4be2-aea1-f5c13c61b3a1: url('https://www.inquirer.net/wp-content/uploads/2024/12/SMDC-HenrySy_980x80.gif');}#inq-banner-2021-FT-survey{--wpr-bg-72defa36-fac1-48cf-8c3c-8fc9a4073248: url('https://www.inquirer.net/wp-content/uploads/2024/12/SMDC-HenrySy_300x75.gif');}#inq-banner-2021-FT-survey{--wpr-bg-712caa8d-ad28-4e0f-a6d0-e796f1c264ed: url('https://www.inquirer.net/wp-content/uploads/2024/12/SMDC-HenrySy_300x75.gif');}#inq-banner-2021-FT-survey{--wpr-bg-ef8eb10e-7cb2-4dc0-a36a-54c968498634: url('https://www.inquirer.net/wp-content/uploads/2024/12/SMDC-HenrySy_300x75.gif');}#inq-banner-2021-FT-survey{--wpr-bg-12188460-23ac-4059-a8cc-169f01f5e6fc: url('https://www.inquirer.net/wp-content/uploads/2024/12/SMDC-HenrySy_300x75.gif');}#inqplus-cta-wrap{--wpr-bg-2180dbe1-c476-45a2-928c-195b61c23c89: url('/single2017/images/inqplus-sub/inqplus-cta-bg1.png');}#newsletter-cta-wrap{--wpr-bg-b5c76de2-d794-4cfa-85ca-14ee4ffed5ce: url('/single2017/images/inqplus-sub/inqplus-cta-bg1.png');}

黑料社

FOLLOW US:

Subscribe to our daily newsletter

Your subscription could not be saved. Please try again.

Your subscription has been successful.

By providing an email address. I agree to the and acknowledge that I have read the .

Moderna says COVID-19 vaccine 94.5% effective

Agence France-Presse / 08:42 PM November 16, 2020

Moderna says COVID-19 vaccine 94.5% effective

(FILES) In this file photo taken on August 13, 2020 Biotechnology company Moderna protocol files for COVID-19 vaccinations are kept at the Research Centers of America in Hollywood, Florida. (Photo by CHANDAN KHANNA / AFP)

Washington, United States — Moderna on Monday announced its experimental vaccine against COVID-19 was shown to be 94.5 percent effective based on early results from a clinical trial with more than 30,000 participants.

“This positive interim analysis from our Phase 3 study has given us the first clinical validation that our vaccine can prevent COVID-19 disease, including severe disease,” said Stephane Bancel, Moderna’s CEO.

Your subscription could not be saved. Please try again.

Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the and acknowledge that I have read the .

For more news about the novel coronavirus click
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this

READ NEXT

Esperon takes witness stand, insists Sison, other Reds behind ...

De Lima questions DOJ’s move vs her lawyers: They’...

EDITORS' PICK

MOST READ

Second 6/55 jackpot winner for December bags P202.5 million 鈥� PCSO

www

globalnation

entertainment

business

business

globalnation

TAGS: 2019-nCoV, China, Coronavirus, COVID-19, Health, Moderna, NcoV, nCoV update, 黑料社, Outbreak, pandemic, vaccine, Virus, world, world news, Wuhan

Your subscription could not be saved. Please try again.

Your subscription has been successful.

Disclaimer: Comments do not represent the views of 黑料社. We reserve the right to exclude comments which are inconsistent with our editorial standards. FULL DISCLAIMER

© Copyright 1997-2024 黑料社 | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies.